Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81

0488706 - ÚEB 2019 RIV NL eng J - Článek v odborném periodiku
Jorda, Radek - Bučková, Zuzana - Řezníčková, Eva - Bouchal, J. - Kryštof, Vladimír
Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81.
Biochimica Et Biophysica Acta-Molecular Cell Research. Roč. 1865, č. 2 (2018), s. 354-363. ISSN 0167-4889. E-ISSN 1879-2596
Grant CEP: GA MŠMT(CZ) LO1204; GA MŠMT(CZ) LO1304
Institucionální podpora: RVO:61389030
Klíčová slova: Androgen receptor * Cyclin-dependent kinase * Inhibitor * Phosphorylation * Serine 81
Obor OECD: Biochemistry and molecular biology
Impakt faktor: 4.739, rok: 2018

Several studies have revealed that cyclin-dependent kinases (CDK) can mediate phosphorylation of steroid receptors at multiple sites, including serine 81 of the androgen receptor (AR). Phosphorylation of S81 is required for AR nuclear translocation, an association with chromatin and also regulates endogenous AR-regulated transcription in response to hormones. Up to date, S81-phosphorylation has been studied using different CDK inhibitors. Nevertheless, most inhibitors are non-selective or have unknown selectivity. We investigated the selectivity of commercially available CDK inhibitors and identified compounds that will be suitable for further studies to identify the CDKs responsible for S81-AR phosphorylation. We confirmed the positive impact of CDK1 and CDK9 on phosphorylation of S81-AR and its transcriptional activity. Although CDK1-mediated phosphorylation was previously shown to occur during mitosis, our experiments did not confirm this finding. By using chemical and genetic inhibition techniques, we identified that CDK2 contributes to S81-AR phosphorylation and transactivation while CDK4 was not shown to be involved in this process.
Trvalý link: http://hdl.handle.net/11104/0283248